Mallinckrodt posts $2.16 million operating loss for March period

By Sarah Lizee

Olympia, Wash., April 27 – Mallinckrodt plc reported a $2.16 million operating loss on zero net sales for the period of Feb. 27 through March 26, according to its monthly operating report filed Monday with the U.S. Bankruptcy Court for the District of Delaware.

The net loss for March was $7.49 million.

The company listed $2.93 million of cash and cash equivalents as of March 26.

Dublin-based Mallinckrodt develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. The company filed Chapter 11 bankruptcy on Oct. 12, 2020 under case number 20-12522.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.